Targeted therapies redefined

We are redefining “targeted” therapies. Aided by advances in the understanding of tumor cell biology and drug design, our cancer therapies bind to unique surface molecules that differentiate cancer cells from normal cells. We selectively obliterate cancer cells through a rapid and physical mechanism of cell membrane disruption, creating a true advance over both imprecise and toxic systemic chemotherapies and targeted therapies that act on individual cell-signaling pathways, where resistance is difficult to overcome.

Our vision is a new class of therapies that have a durable treatment effect across many types of cancer and creates unique therapeutic opportunities for rare cancers that have no treatment options today.